TOTAL NEOADJUVANT THERAPY
Clinical trials for TOTAL NEOADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new TOTAL NEOADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for TOTAL NEOADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost rectal cancer survival
Disease control Recruiting nowThis phase 3 trial tests whether adding an immunotherapy drug (HLX10) to standard chemotherapy and radiation before surgery improves outcomes for people with locally advanced rectal cancer. It compares short-course versus long-course radiation, both followed by immunotherapy and …
Matched conditions: TOTAL NEOADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy aims to boost rectal cancer remission
Disease control Recruiting nowThis study is for people with locally advanced rectal cancer that hasn't spread. It tests whether adding an immunotherapy drug (PD-1 inhibitor) to a standard treatment plan (short-course radiation plus chemotherapy and targeted therapy) can lead to a complete disappearance of the…
Matched conditions: TOTAL NEOADJUVANT THERAPY
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC